Clinical Trials Logo

Clinical Trial Summary

Primary objective - To study the stability of different phenotypes and endotypes of asthma at 3, 5, and 7 years of follow-up and - in MEGA COHORT and in patients on biologic treatment Secondary objective(s) - To study biomarkers variation post-treatment in patients with and without Nasal Polyposis - To demonstrate the existence of different subtypes of eosinophils that may be phenotypically and functionally heterogeneous - To increase the number of patients in the cohort on biologic treatment to reach at least 900 (400 over the current cohort).


Clinical Trial Description

Open-labeled National, Multicenter Non-interventional on the therapeutic strategy, Prospective (longitudinal) Disease registry, 3 years of follow-up 1. Correlation between non-invasive T2 markers (FeNO, blood eosinophils) versus inflammatory markers in sputum (eosinophils, periostin, NO, etc.) 2. Cluster analysis in both cohorts. 3. Analysis of some treatable traits on asthma control in MEGA cohort (BMI, anxiety and depression scale, exercise). 4. To characterize exacerbations (numbers, ICU admissions, treatments compliance, etc). 5. Analysis of compliance with asthma medications. 6. Analysis of patients with phenotype T2-LOW in MEGA cohort. 7. Analysis of patients with undetectable total IgE ( < 10 UI/L). 8. Role of microRNA in diagnosis, follow-up and variations after treatments. 9. Analysis of alarmins (TSLP, IL-33 e IL-25) and IL-6 in blood and sputum. 10. To Immunophenotype eosinophils by single-cell analysis in blood and sputum at baseline and post-biological treatment. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06163807
Study type Observational [Patient Registry]
Source Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Contact Joaquin S Sastre
Phone 34609835363
Email jsastre@fjd.es
Status Not yet recruiting
Phase
Start date April 1, 2024
Completion date January 2, 2026

See also
  Status Clinical Trial Phase
Recruiting NCT04395937 - Effects of Regular Submaximal Exercise on Asthma Control and Quality of Life in Patients With Persistent Symptoms N/A
Completed NCT01305369 - The Effect of Prasugrel on Bronchial Hyperreactivity and on Markers of Inflammation in Patients With Chronic Asthma Phase 4
Completed NCT00739297 - The Safety and Effectiveness of MK0476 (Montelukast) in Patients With Chronic Asthma (0476-388) Phase 1
Completed NCT02386722 - Intervention to Improve Inhalative Adherence N/A